Benzinga | Mar 9, 2021 09:16AM EST

Intersect ENT Q4 EPS $(0.54) Misses $(0.32) Estimate, Sales $28.20M Beat $27.92M Estimate

Intersect ENT (NASDAQ:XENT) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.32) by 68.75 percent. This is a 116 percent decrease over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $28.20 million which beat the analyst consensus estimate of $27.92 million by 1.00 percent. This is a 11.19 percent decrease over sales of $31.75 million the same period last year.